Signaling Pathways - DCLK2 - IMPDH - Telomerases - c-MET
清除全部
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂
- B1112 MerimepodibTarget: IMPDHSummary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
- A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂
- A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂
- A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂
- A2307 PHA-6657521 CitationTarget: c-METSummary: c-Met的ATP竞争性、有效的、选择性抑制剂
- A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂
- A3558 LRRK2-IN-11 CitationTarget: LRRK2|DCLK2Summary: LRRK2抑制剂
- A3327 Costunolide中文名: 木香烃内酯Target: FPTase|TelomerasesSummary: BMM分化抑制剂